Key result
Rare primary prostate synovial sarcoma affects younger men presenting with obstructive symptoms and low PSA.
Why the study?
Primary synovial sarcoma of the prostate is exceptionally rare, and its nonspecific presentation with often normal or low PSA levels may delay diagnosis.
Case Report (n=18)
Primary prostatic synovial sarcoma is a rare entity that can be managed with a multidisciplinary approach including surgery, radiotherapy, and chemotherapy, yielding disease-free survival at 20 months in this case.
Supports multidisciplinary care in rare prostatic synovial sarcoma; hypothesis-generating and should not yet change practice.
Primary synovial sarcoma of the prostate is exceptionally rare.Its nonspecific presentation and often normal or low prostate-specific antigen (PSA) levels may delay diagnosis.A 49-year-old man presented with lower urinary tract symptoms and gross hematuria.Digital rectal examination revealed a markedly enlarged, firm, irregular prostate.The serum PSA level was 0.34 ng/mL.Pelvic magnetic resonance imaging showed a 9.4 × 7.4 × 6.5 cm heterogeneous prostatic mass with loss of the rectoprostatic fat plane, without definitive evidence of metastatic disease on staging.Transrectal ultrasound-guided biopsy demonstrated a monophasic spindle-cell neoplasm with immunohistochemical findings consistent with synovial sarcoma.Robot-assisted radical prostatectomy was converted to an open approach to facilitate resection.Tumor was identified in tissue from the rectoprostatic margin, while the overall margin status was indeterminate because of tumor fragmentation, raising concern for microscopic residual disease.The patient received adjuvant pelvic radiotherapy followed by doxorubicin and ifosfamide chemotherapy.At 20 months, he remained alive without radiologic evidence of recurrence or metastasis.Primary prostatic synovial sarcoma should be considered in younger to middle-aged patients with obstructive urinary symptoms, a large prostatic mass, and a normal or low PSA level.Diagnosis relies on histopathologic assessment, supported by immunohistochemistry and molecular testing whenever available.Management should be individualized through multidisciplinary discussion.
No takes yet. Share an insight, caveat, or question.
Alghamdi et al. (2026) conducted a case report in Primary synovial sarcoma of the prostate (n=18). Multidisciplinary management (surgery, chemotherapy, radiotherapy) was evaluated on Clinical outcome (survival and disease recurrence). Primary synovial sarcoma of the prostate is a rare malignancy typically affecting younger to middle-aged men, presenting with obstructive symptoms and low PSA, and managed through individualized multidisciplinary care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: